Breakthrough on the Horizon for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients (Part 1 of 2)

Written By Alana Karran A biomarker has been found in Myalgic Encephalomyelitis (ME), also known as Chronic Fatigue Syndrome (CFS). Griffith University in Australia discovered the biomarker – a measurable substance that helps identify the pathology of an illness – while studying natural killer cells in ME/CFS patients and healthy controls. Myalgic Encephalomyelitis (ME), also known as Chronic Fatigue Syndrome (CFS), is considered a rare disorder, even though more people suffer from it worldwide than commonly recognized diseases such as Multiple Sclerosis (MS). Similar to MS, ME is a neurological condition that impacts the central nervous system. First documented in 1934, ME has been attributed to illnesses much earlier, including in famous individuals such as Charles Darwin, Madame Curie and Florence Nightingale. Famous current day sufferers include Laura Hillenbrand, Cher and Stevie Nicks. Myalgic Encephalomyelitis is best known for its